MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CELC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Celcuity (CELC) Ownership - Who owns Celcuity?

Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
155
Web
https://www.celcuity.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.26B
P/E Ratio
N/A
Total Cash
387.06M
Projected Growth
N/A
Total Debt
323.44M
Revenue
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash/Share
7.94
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CELC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CELC
A.I. Advisor
published General Information

General Information

a biotechnology company develops novel diagnostic tests

Industry Biotechnology

Profile
Details
Industry
Miscellaneous Commercial Services
Address
16305 36th Avenue North
Phone
+1 763 392-0767
Employees
155
Web
https://www.celcuity.com